KROS · Keros Therapeutics, Inc. · Debt
Market Cap
$224.44M
Shares
19.83M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
94 filings
94 filers
Visit website
Investor relations